Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PhreesiaLTS:0A23 65 FCF Margin % is 12.50% as of Apr. 2026. GuruFocus rates LTS:0A23 with a GF Score™ of 65/100 and a GF Value™ of $70.77. The stock has 4 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Phreesia ranks better than 79.97% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Phreesia's Free Cash Flow for the
three
months ended in Apr. 2026 was $16.4 Mil. Phreesia's Revenue for the
three
months ended in Apr. 2026 was $130.9 Mil. Therefore, Phreesia's FCF Margin % for the quarter that ended in Apr. 2026 was 12.50%.
The historical rank and industry rank for Phreesia's FCF Margin % or its related term are showing as below:
LTS:0A23'
s FCF Margin % Range Over the Past 10 Years
Min: -49.48 Med: -11.98 Max: 12.78
Current: 12.78
During the past 9 years, the highest FCF Margin % of Phreesia was 12.78%. The lowest was -49.48%. And the median was -11.98%.
LTS:0A23's FCF Margin % is ranked better than 79.97% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.39
vs LTS:0A23: 12.78
Phreesia FCF Margin % Related Terms
Phreesia FCF Margin % Historical Data
* Premium members only.
The historical data trend for Phreesia's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0A23 vs EVH, CTEV, MDRX: FCF Margin % Comparison
For the Health Information Services subindustry, Phreesia's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phreesia FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Phreesia's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phreesia (LTS:0A23) has a FCF Margin % of 12.50% as of Apr. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Phreesia and its competitors. According to the industry distribution chart, Phreesia ranks #134 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 20%.
Is Phreesia's FCF Margin % too high?
Phreesia's current FCF Margin % is 12.50%. The Healthcare Providers & Services industry median FCF Margin % is 3.39. Phreesia's value of 12.50% is 268.7% above this industry median. Based on the distribution chart, Phreesia ranks #134 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Phreesia has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Phreesia's FCF Margin % compare to EVH and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Phreesia ranks #134 out of 669 companies for FCF Margin %. This places Phreesia in the top 20% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.39. Phreesia's value of 12.50% is 268.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phreesia's current FCF Margin % of 12.50% is 268.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Phreesia and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phreesia's current FCF Margin % is 12.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Phreesia (LTS:0A23) has a current FCF Margin % of 12.50%. The stock's GF Value™ is $70.77, compared to a current price of $28.50 — trading 59.7% below its estimated fair value. The current FCF Margin % is 12.50% and 268.7% above the Healthcare Providers & Services industry median of 3.39. Phreesia's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Phreesia (LTS:0A23), the current FCF Margin % is 12.50% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phreesia (LTS:0A23) Overvalued in 2026?
Based on GuruFocus' analysis, Phreesia stock appears to be undervalued.
The current stock price of $28.50 is trading 59.7% below its estimated GF Value™ of $70.77.
Key valuation signals for LTS:0A23:
FCF Margin %: 12.50%
GF Value™: $70.77 vs. price of $28.50 (59.7% below fair value)
Industry Position: 268.7% above the Healthcare Providers & Services median (#134 of 669)
No single metric tells the full story. See the LTS:0A23 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score
Get the complete analysis for LTS:0A23
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0A23 has been successfully added to your 
